Insulin resistance is closely associated with an increased risk of subclinical atherosclerosis in patients with rheumatoid arthritis (RA). Anti-TNF therapy reduces insulin resistance and improves insulin sensitivity in patients with severe RA. New findings have shown, however, that the efficacy of these agents in this regard is impaired by obesity.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The outcomes of bariatric surgery on rheumatoid arthritis disease activity: a prospective cohort study
Scientific Reports Open Access 21 February 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Stavropoulos-Kalinoglou, A. et al. Anti tumour necrosis factor α therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res. Ther. 14, R160 (2012).
Lebovitz, H. E. Insulin resistance: definition and consequences. Exp. Clin. Endocrinol. Diabetes 109 (Suppl. 2), S135–S148 (2001).
González-Gay, M. A., González-Juanatey, C. & Martin, J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin. Arthritis Rheum. 35, 8–17 (2005).
Dessein, P. H., Tobias, M. & Veller, M. G. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J. Rheumatol. 33, 2425–2432 (2006).
Despres, J. P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881–887 (2006).
Chung, C. P. et al. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 58, 2105–2112 (2008).
González-Gay, M. A. et al. Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 24, 83–86 (2006).
González-Gay, M. A., González-Juanatey, C., Vazquez-Rodriguez, T. R., Miranda-Filloy, J. A. & Llorca, J. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-α therapy. Ann. NY Acad. Sci. 1193, 153–159 (2010).
Miranda-Filloy, J. A. et al. TNF-α antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients. Clin. Exp. Rheumatol. (in press).
Huvers, F. C., Popa, C., Netea, M. G., van den Hoogen, F. H. & Tack, C. J. Improved insulin sensitivity by anti TNFα antibody treatment in patients with rheumatic diseases. Ann. Rheum. Dis. 66, 558–559 (2007).
Acknowledgements
The studies conducted by Dr González-Gay were supported by two grants from 'Fondo de Investigaciones Sanitarias' PI06-0024 and PI09/007/48 (Spain) and were partially supported by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII) Spain.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
González-Gay, M., González-Juanatey, C. Obesity impairs efficacy of anti-TNF therapy in patients with RA. Nat Rev Rheumatol 8, 641–642 (2012). https://doi.org/10.1038/nrrheum.2012.158
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2012.158
This article is cited by
-
The outcomes of bariatric surgery on rheumatoid arthritis disease activity: a prospective cohort study
Scientific Reports (2020)